Search - tctmd.com

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

Presenter: Gill Buchanan, Alaide Chieffo, Chiara Bernelli, Matteo Montorfano, Mauro Carlino, Azeem Latib, Filippo Figini, Irene Franzoni, Santo Ferrarello, Alfonso Ielasi, Francesco Sacco, Massimo Slavich, Alessandro Durante, Alfredo Castelli, Antonio Colombo

January 31, 2013

Presentation TCT 2013

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Presenter: Seung-Jin Oh, Armando Tellez, Maxwell Afari, Gerard Conditt, Jenn McGregor, Yanping Cheng, Geng-Hua Yi, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Serial Evaluation Of Peri-strut Low Intensity Area On Optical Coherence Tomography After Drug-eluting Stents Implantation

Presenter: Eui Im, Byeong-Keuk Kim, Jung-Sun Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong

January 31, 2013

Presentation TCT 2013

Randomized Comparison of Direct Stenting with Conventional and Provisional Stent Implantation in Elective PCI Patients Using Bare Metal and Drug Eluting Stents

Presenter: Samer Somi, Wouter Remkes, Jan-Henk Dambrink, Marcel Gosselink, Jan Hoorntje, Harry Suryapranata, Jan Paul Ottervanger, Arnoud van 't Hof

January 31, 2013

Presentation TCT 2013

Outcomes According to Sex Following Unprotected Left Main Stenting With Drug-Eluting Stents: The Milan Experience

Presenter: Gill Buchanan, Alaide Chieffo, Chiara Bernelli, Alfonso Ielasi, Matteo Montorfano, Azeem Latib, Mauro Carlino, Filippo Figini, Irene Franzoni, Francesco Giannini, Alessandro Durante, Santo Ferrarello, Alfredo Castelli, Antonio Colombo

January 31, 2013

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

Long Term Outcomes Of Simple And Complex Coronary Bifurcation Lesions (CBL) Treated With Drug Eluting Stents (DES)

Presenter: Leonard Ngunga, Po Kee Cheung, Shantu Bundhoo, Neil Brass, Benjamin Tyrrell, Raymond Leung, Micha Dorsch, William Hui

January 31, 2013

Advertisement

Colchicine Reduces BMS Restenosis in Diabetic Patients

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

Drug-Eluting Stents: Past, Present, and Future

REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests

Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Medtronic Approved to Update Resolute Integrity Stent’s ‘CE’ Mark Labeling on Dual Antiplatelet Therapy

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Serial Evaluation Of Peri-strut Low Intensity Area On Optical Coherence Tomography After Drug-eluting Stents Implantation

Randomized Comparison of Direct Stenting with Conventional and Provisional Stent Implantation in Elective PCI Patients Using Bare Metal and Drug Eluting Stents

Outcomes According to Sex Following Unprotected Left Main Stenting With Drug-Eluting Stents: The Milan Experience

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Long Term Outcomes Of Simple And Complex Coronary Bifurcation Lesions (CBL) Treated With Drug Eluting Stents (DES)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content